Source link : https://www.newshealth.biz/health-news/mace-risk-similar-among-biologics-for-psoriasis-psa/
TOPLINE: Rates of major adverse cardiovascular events do not differ significantly among individual biologics used for psoriasis or psoriatic arthritis (PsA), a database analysis finds. METHODOLOGY: Data from the TriNetX health records database included 32,758 patients treated with TNF inhibitors (TNFi, 62.9%), interleukin-17 inhibitors (IL-17i, 15.4%), IL-23i (10.7%), and IL-12i/IL-23i (10.7%). The researchers calculated time-dependent […]
Author : News Health
Publish date : 2024-07-25 12:55:00
Copyright for syndicated content belongs to the linked Source.
Categories